PARIS, February 24 /PRNewswire/ --

- 'Laptop Protection From BT MobileXpress', Powered by Alcatel-Lucent, Simplifies the Security and Management of Mobile Computers

Alcatel-Lucent (Euronext Paris and NYSE: ALU) today announced a strategic relationship with BT Global Services, a world-leading provider of networked IT services.

NEW YORK, February 24 /PRNewswire/ --

LONDON, February 24 /PRNewswire/ --

Early detection is the key focus of cancer diagnostics. Traditional testing methods such as immunoassay testing are facing fierce competition from evolving segments such as nucleic acid amplification technology (NAT) and immunohistochemistry testing. The ability to prove the clinical utility and practical use of the test within a laboratory is one of the essential requirements to be successful in this market.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost Sullivan (http://www.drugdiscovery.frost.com), European Cancer IVD Market, finds that the market earned revenues of $623.5 million in 2008 and estimates this to reach $1.5 billion in 2015.

LONDON, February 24 /PRNewswire/ --

- As British Airways and BBC Worldwide Fall Out of the Top 10

Internet giant Google has - for the second year in a row - notched the top slot in the prestigious annual Business Superbrands survey, compiled by The Centre for Brand Analysis (TCBA) on behalf of the Superbrands organisation. To generate the rankings TCBA analysed the views of an Expert Council and over 1,500 business professionals.

LONDON, February 24 /PRNewswire/ --

- Syndicate Comprises Leading Sector Investors Clarus Ventures, MVM Life Science Partners and Novartis Option Fund

Heptares Therapeutics Ltd, the drug discovery company focused on drugs targeting G-protein-coupled receptors (GPCRs), announces today it has raised GBP21 million (US$30 million) of equity finance in a successful Series A private round from three blue-chip international venture capital firms. Clarus Ventures led the syndicate, which includes the founding investor, MVM Life Science Partners, and the Novartis Option Fund. All three investors contributed equally.

SHENZHEN, China, February 24 /PRNewswire/ --

- Company Plans to Make System Available by Q3 2009

FLORHAM PARK, New Jersey, February 24 /PRNewswire/ --

Global Crossing (Nasdaq: GLBC), a leading global IP solutions provider, today announced its intent to provide content delivery network (CDN) services by forming relationships with several vendors to give its enterprise customers the flexibility to use the appropriate technology required to meet their specific content needs.

This marks Global Crossing's entry into the CDN market and will enable the company to offer customers industry-leading solutions for the delivery of rich media content and enterprise applications. A CDN enables users to watch a high-definition movie, make an online purchase, listen to music, play a video game, or download a software package.

LONDON, February 24 /PRNewswire/ --

Wireless power is emerging as a popular concept since the profusion of personal and portable electronic devices has created a need for a convenient means to power these gadgets, eliminating the inconvenience and mess of several chargers and wires. Industries too echo this sentiment, as wires represent a burden in terms of cost and maintenance. Scientists are considering several technologies for such applications.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

LONDON, February 24 /PRNewswire/ --

- 'Stain on university's 800th birthday celebrations,' says Unite

Plans to axe more than 150 jobs at the world-famous Cambridge University Press (CUP) are to be debated by the Cambridge City Council on Thursday (26 February).

Proposals by the profitable CUP to cuts the jobs in its printing division and the publishing education group have been described by Unite, the largest union in the country as 'an irredeemable stain on Cambridge University's reputation as its celebrates its 800th anniversary'.

BEIJING, February 24 /PRNewswire/ --